- Home
- NKTX vs ZJYL Comparison
NKTX vs ZJYL Comparison
Compare NKTX & ZJYL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTX
- ZJYL
- Stock Information
- Founded
- NKTX 2015
- ZJYL 2006
- Country
- NKTX United States
- ZJYL China
- Employees
- NKTX N/A
- ZJYL N/A
- Industry
- NKTX Biotechnology: Pharmaceutical Preparations
- ZJYL Industrial Specialties
- Sector
- NKTX Health Care
- ZJYL Consumer Discretionary
- Exchange
- NKTX Nasdaq
- ZJYL Nasdaq
- Market Cap
- NKTX 123.5M
- ZJYL 111.3M
- IPO Year
- NKTX 2020
- ZJYL 2023
- Fundamental
- Price
- NKTX $2.06
- ZJYL $0.50
- Analyst Decision
- NKTX Strong Buy
- ZJYL
- Analyst Count
- NKTX 5
- ZJYL 0
- Target Price
- NKTX $13.50
- ZJYL N/A
- AVG Volume (30 Days)
- NKTX 773.5K
- ZJYL 200.0K
- Earning Date
- NKTX 11-06-2025
- ZJYL 08-20-2025
- Dividend Yield
- NKTX N/A
- ZJYL N/A
- EPS Growth
- NKTX N/A
- ZJYL N/A
- EPS
- NKTX N/A
- ZJYL 0.01
- Revenue
- NKTX N/A
- ZJYL $22,826,624.00
- Revenue This Year
- NKTX N/A
- ZJYL N/A
- Revenue Next Year
- NKTX N/A
- ZJYL N/A
- P/E Ratio
- NKTX N/A
- ZJYL $51.10
- Revenue Growth
- NKTX N/A
- ZJYL 13.42
- 52 Week Low
- NKTX $1.31
- ZJYL $0.50
- 52 Week High
- NKTX $4.55
- ZJYL $2.91
- Technical
- Relative Strength Index (RSI)
- NKTX 46.37
- ZJYL 32.44
- Support Level
- NKTX $2.10
- ZJYL $0.56
- Resistance Level
- NKTX $2.24
- ZJYL $0.60
- Average True Range (ATR)
- NKTX 0.10
- ZJYL 0.04
- MACD
- NKTX 0.01
- ZJYL -0.00
- Stochastic Oscillator
- NKTX 39.39
- ZJYL 16.68
About NKTX Nkarta Inc.
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.
About ZJYL JIN MEDICAL INTERNATIONAL LTD.
Jin Medical International Ltd offers rehabilitation equipment. It is engaged in the design, development, manufacturing, and sales of wheelchairs and other living aids products to be used by people with disabilities or impaired mobility. The company's products are sold to distributors in both China and overseas markets. Its product offerings comprise Wheelechaire serirs, Bath products, oxygen machines, and nursing products. Geographically, it generates the majority of its revenue from Japan.